Literature DB >> 12460134

Correlates of pre-treatment drop-out among persons with marijuana dependence.

Janice Vendetti1, Bonnie McRee, Michael Miller, Kenneth Christiansen, James Herrell.   

Abstract

AIMS: Our objective was to identify client characteristics and other factors associated with pre-treatment drop-out by people with marijuana dependence. DESIGN AND PARTICIPANTS: Data from the Marijuana Treatment Project's screening assessment were used to examine correlates of pre-treatment drop-out. Information from all eligible study participants (n = 813) (i.e. those who were interested in receiving treatment for their marijuana dependence and were determined to be eligible for the randomized treatment efficacy trial) was used to examine differences between the 450 participants who initiated treatment (by enrolling in the trial) and the 363 individuals who declined enrollment.
SETTING: The study was conducted at three community-based outpatient treatment facilities in Farmington, CT, Seattle, WA and Miami, FL. MEASUREMENTS: The information gathered in the screening interview included demographic characteristics, residential stability variables, employment and education history and referral source. Substance use variables included the number of days and the number of times per day marijuana was used, self-perceived dependence on marijuana, alcohol or other drugs, other drug use history and current treatment (i.e. substance abuse, medical, psychiatric) situation.
FINDINGS: Stepwise logistic regression was conducted to confirm variables associated with treatment initiation in bivariate analyses. Pre-treatment drop-out was associated with being younger, unmarried, unemployed, less educated and Asian American or Native American. It was also associated with self-perceived dependence on marijuana and use of other drugs.
CONCLUSIONS: By recognizing demographic and substance use factors that may serve as barriers for individuals accessing treatment for marijuana dependence, clinicians may target clients with these characteristics proactively to encourage treatment initiation and subsequent attendance.

Entities:  

Mesh:

Year:  2002        PMID: 12460134     DOI: 10.1046/j.1360-0443.97.s01.8.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  7 in total

Review 1.  The marijuana withdrawal syndrome: diagnosis and treatment.

Authors:  Margaret Haney
Journal:  Curr Psychiatry Rep       Date:  2005-10       Impact factor: 5.285

2.  The Effect of Positive and Negative Affect on Early Treatment Milestones in the Context of Integrated Smoking Treatment.

Authors:  Lorra Garey; Brooke Y Kauffman; Kara F Manning; Samar A Taha; Norman B Schmidt; Clayton Neighbors; Michael J Zvolensky
Journal:  J Addict Med       Date:  2019 Jan/Feb       Impact factor: 3.702

3.  Early participant attrition from clinical trials: role of trial design and logistics.

Authors:  Azfar-E-Alam Siddiqi; Alla Sikorskii; Charles W Given; Barbara Given
Journal:  Clin Trials       Date:  2008       Impact factor: 2.486

Review 4.  Psychosocial interventions for cannabis use disorder.

Authors:  Peter J Gates; Pamela Sabioni; Jan Copeland; Bernard Le Foll; Linda Gowing
Journal:  Cochrane Database Syst Rev       Date:  2016-05-05

5.  When Marijuana Is Used before Cigarettes or Alcohol: Demographic Predictors and Associations with Heavy Use, Cannabis Use Disorder, and Other Drug-related Outcomes.

Authors:  Brian J Fairman; C Debra Furr-Holden; Renee M Johnson
Journal:  Prev Sci       Date:  2019-02

6.  Substance use consequences, mental health problems, and readiness to change among Veterans seeking substance use treatment.

Authors:  David H Morris; Alan K Davis; Kirstin J Lauritsen; C Martin Rieth; Mark M Silvestri; Jamie J Winters; Stephen T Chermack
Journal:  J Subst Abuse Treat       Date:  2018-08-19

7.  Examining attrition rates at one specialty addiction treatment provider in the United States: a case study using a retrospective chart review.

Authors:  David Loveland; Hilary Driscoll
Journal:  Subst Abuse Treat Prev Policy       Date:  2014-09-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.